UNSPSC 42202102: Brachytherapy catheters or syringes or inserters or applicators

In this classification, this commodity indicates a product used as a flexible tube, syringe or inserted through a narrow opening into a body cavity in a brachytherapy procedure. US FDA regulates Brachytherapy catheters or syringes or inserters or applicators under 21 CFR 892.5730 and under FDA product code KXK. Most nations, for tariff and trade purposes, schedule these products under HS 901839.

UNSPSC 42202102 Brachytherapy catheters or syringes or inserters or applicators is a Commodity code that nominally covers specialized medical devices for cancer radiation therapy delivery. Recent state and local procurement activity under this code shows minimal alignment with the code's stated scope. The five most recent opportunities posted between May and August 2026 span special education supplies through a cooperative purchasing vehicle, durable medical equipment and rehabilitation services in Texas, gym fitness equipment in California, athletic training services for public safety personnel in Arizona, law enforcement equipment through a multistate cooperative, and school district athletic and conditioning supplies in Texas. None of these solicitations explicitly references brachytherapy devices, catheters, applicators, or radiation oncology equipment; the code appears to have been applied to these opportunities as a catchall or administrative classifier rather than reflecting actual procurement need for brachytherapy-specific products.

The issuing-body mix includes state health and human services agencies, county and city governments, school districts, and cooperative purchasing vehicles serving multiple jurisdictions across Texas, California, Arizona, Washington, and Minnesota. The Texas Health and Human Services Commission's durable medical equipment procurement (HHS0017173, due June 2, 2026) is the closest substantive fit, encompassing orthotics, prosthetics, communication aids, and wound care supplies across eleven geographic service regions under an HUB set-aside with 21.1 percent utilization target and a five-year term through August 2031; however, even this opportunity does not name brachytherapy devices as a category. No recent opportunities specifically soliciting brachytherapy catheters, syringes, inserters, or applicators appear in the available posting block. Firms pursuing work under this code should verify directly with issuing bodies whether brachytherapy-related products are genuinely sought or whether the code assignment reflects cataloging mismatch.